Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Azole Therapy in Chronic Pulmonary Aspergillosis: A Randomized Comparative Study of Itraconazole and Posaconazole Integrating Clinical Outcomes, Azole Exposure, and Resistance Surveillance

NCT07825259 is registered in ClinicalTrials.gov with Post Graduate Institute of Medical Education and Research, Chandigarh as lead sponsor.

NCT NCT07825259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07825259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Azole Therapy in Chronic Pulmonary Aspergillosis: A Randomized Comparative Study of Itraconazole and Posaconazole Integrating Clinical Outcomes, Azole Exposure, and Resistance Surveillance
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
December 31, 2029
Enrollment
220 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pulmonary aspergillosis